CASI Pharmaceuticals, Inc (DE) Annual Earnings Per Share, Basic in USD/shares from 2020 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2022.
  • CASI Pharmaceuticals, Inc (DE) Earnings Per Share, Basic for the quarter ending December 31, 2022 was -2.01 USD/shares, a 48.9% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Earnings Per Share, Basic for the twelve months ending December 31, 2022 was -3.01 USD/shares, a 11.9% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Earnings Per Share, Basic for 2022 was -3.01 USD/shares, a 11.9% decline from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Earnings Per Share, Basic for 2021 was -2.69 USD/shares, a 38.4% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$3 $0 -11.9% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-26
2021 -$3 +$1.68 +38.4% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-26
2020 -$4 Jan 1, 2020 Dec 31, 2020 20-F 2023-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.